Sunday, November 21, 2010
Print Current Day:
|
|
SESSION 42 SCHEDULE | |
Sunday
SESSION 42:
NEW DEVELOPMENTS, CONCEPTS AND TECHNIQUES FOR EVALUATING CAROTID PLAQUES (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
6:45 AM - 6:50 AM | How To Make Ultrasound (Duplex) A Useful Surveillance Tool And Decrease The Number Of CTs After EVAR: Can Duplex Velocity Differences In Graft Limbs Indicate An Endoleak? |
6:51 AM - 6:56 AM | Immune Mediated Coagulopathy: A Complication Of Bovine Thrombin: How Can It Be Recognized, Prevented And Treated? |
6:57 AM - 7:02 AM | Inadvertent Arterial Injury Secondary To Treatment Of Varicose Veins And Venous Insufficiency By Surgery And Foam: Diagnosis And Treatment |
7:03 AM - 7:08 AM | Practical Measures For Radiation Protection During Endovascular Procedures |
7:09 AM - 7:14 AM | How To Manage Infected Carotid Patches |
7:15 AM - 7:20 AM | Computerized Models Of Displacement Forces Can Be Helpful In Predicting Migration Of Endografts After EVAR And Can Help In Graft Selection |
7:21 AM - 7:26 AM | Standardized And Semiautomatic Noninvasive Evaluation Of Carotid Plaque Activity For Predicting Stroke Risk In Asymptomatic Patients: The Activity Index |
7:27 AM - 7:32 AM | Relationship Between Atherosclerotic Plaque Composition By IVUS And Cerebral Embolization |
7:33 AM - 7:38 AM | New Techniques (PET And MSOT [Multispectral Optacoustic Tomography] Scanning) For Imaging Carotid Plaques To Determine Their Vulnerability To Have Strokes: Do They Work In Asymptomatic Patients? |
7:39 AM - 7:44 AM | Spinning Of CREST |
7:45 AM - 7:50 AM | Contrast Enhanced Ultrasound To Identify Asymptomatic Carotid Plaques At Risk For Causing A Stroke |
7:51 AM - 7:56 AM | Carotid Plaque Composition Relates To Symptomatic Status Of Patients And The Incidence Of Restenosis: How Should Plaque Composition Influence Treatment? |
7:57 AM - 8:02 AM | Can Asymptomatic Patients With Carotid Plaques Who Are At High Risk For Stroke Be Identified Noninvasively: The ACSRS Study In > 1,000 Patients |
8:03 AM - 8:08 AM | Novel Technique For Assessing Plaque Risk Noninvasively In Patients With Asymptomatic Carotid Stenoses |
8:09 AM - 8:13 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 42.1 - Predictors Of Mortality With Open And Endovascular Treatment Of Ruptured AAAs |
Web-Based Presentation | 42.2 - New Concepts In Effort Thrombosis And Neurogenic Thoracic Outlet Syndrome And How They Are Best Treated |
Web-Based Presentation | 42.3 - C. Difficile Colitis Is Associated With Increased Mortality In All Vascular Surgery Patients |
Web-Based Presentation | 42.4 - Multilayer Stent For The Treatment Of Popliteal Aneurysms |
Web-Based Presentation | 42.5 - CAS vs. CEA: Which Is Best For The Surgeon Who Can Do Both Well? |
Web-Based Presentation | 42.6 - CEA Or CAS Should Be Performed In The Acute Period After A TIA Or Minor Stroke Without Increasing Procedural Risk: How Can This Be Done Safely? |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Sunday
SESSION 43:
MORE ABOUT ABDOMINAL AND THORACIC ANEURYSMS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
8:18 AM - 8:23 AM | Use Of A Large Diameter, Low Profile (8 Fr Delivery System) Balloon Expandable Covered Stent (ADVANTA V12) For The Treatment Of Aortic Coarctation |
8:24 AM - 8:29 AM | New Findings And Interpretations From The CAESAR Small AAA Trial |
8:30 AM - 8:35 AM | New Findings And Interpretations From The PIVOTAL Small AAA Trial |
8:36 AM - 8:41 AM | The Strange Relationship Between Diabetes And AAAs |
Presenters(s):Frank A. Lederle, MD | |
8:42 AM - 8:47 AM | 10 Top Technical Tips For Performing EVAR With Challenging Anatomy |
8:48 AM - 8:53 AM | Predictors Of Poor Outcomes With EVAR Using NSQIP Database: How Can It Help Us Make Better Clinical Decisions? |
8:54 AM - 8:59 AM | Impact Of Obesity On Treatment Outcomes Of AAA Treatment With EVAR And Open Repair: Should Obesity Influence Choice Of Treatment Methods? |
9:00 AM - 9:05 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
9:05 AM - 9:10 AM | Lessons Learned From Late Retreatment After EVAR Failure |
9:11 AM - 9:16 AM | How Can Theoretical Mathematical And Bench Top Models Of Acute Aortic Dissection Be Helpful? |
9:17 AM - 9:22 AM | When Can The Celiac Axis Be Covered Safely During TEVAR: Can There Be Adverse Outcomes And How Can They Be Predicted? |
9:23 AM - 9:28 AM | Debate 28: When The Left Subclavian Artery Is Covered In A TEVAR Procedure, It Must Be Revascularized: The SVS Guidelines Say So |
9:29 AM - 9:34 AM | Debate 28: When The Left Subclavian Artery Is Covered In A TEVAR Procedure, It Should Only Be Revascularized Selectively |
Presenters(s):Timothy A. Resch, MD, PhD | |
9:35 AM - 9:40 AM | Significance Of Air Bubbles In An Aneurysm Sac After TEVAR Or EVAR: How Long Postop Can They Be A Normal Finding? |
9:41 AM - 9:46 AM | Minimal Incisionn Aortic Surgery: An Undertilized But Safe Technique |
9:47 AM - 9:55 AM | Panel Discussion Coffee Available In 3rd Floor Foyer |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 43.1 - Current Guidelines For Treatment Of Small AAAs |
Web-Based Presentation | 43.2 - Debate: Most Type I Endoleaks Are Dangerous And Must Be Treated |
Web-Based Presentation | 43.3 - Debate: Type I And Type II Endoleaks Are Not Always Dangerous And Some Can Be Observed: Under What Conditions? |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Sunday
SESSION 44:
NEW DEVELOPMENTS IN DISEASES OF THE SUPRA-AORTIC TRUNKS, THE VERTEBRALS AND THE CAROTIDS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
9:56 AM - 10:01 AM | Optimal Treatment For Coincident Carotid Or Vertebral Stenosis And Concurrent High-Grade Intracranial Stenosis |
10:02 AM - 10:07 AM | Identifying And Managing The Isolated Cerebral Hemisphere During CAS And CEA |
10:08 AM - 10:13 AM | Takayasu’s Disease Treatment Options: When Is Endovascular Treatment With Stenting Acceptable? |
10:14 AM - 10:19 AM | Are Stent Fractures After Common Carotid And Innominate Stenting Frequent: When Do They Occur And What Should Be Done About Them? |
10:20 AM - 10:25 AM | Long-Term Results Of Vertebral Artery Stenting For Symptomatic Ostial Stenoses: Value And Limitations |
10:26 AM - 10:31 AM | Unusual Application Of Flow Reversal Embolic Protection With Vertebral And Other Lesions |
10:32 AM - 10:37 AM | Can CEA Be Performed Safely On Patients Taking ASA, Plavix And/Or Coumadin Without Stopping The Drugs: Tips And Tricks |
10:38 AM - 10:43 AM | Nationwide US Outcomes For CEA And CAS: Are There Important Differences In Women vs. Men; In Those > 80 vs. Those < 80? |
10:44 AM - 10:49 AM | Have CEA Results Improved Since The Landmark Trials (NASCET, ACAS, Etc.) And Why? |
10:50 AM - 10:55 AM | Debate 29: There Is A Major Role For CAS In Europe And The USA After The Recent Trials |
10:56 AM - 11:01 AM | Debate 29: The Role Of CAS After The Recent Trials Should Be Minimal – Especially In Asymptomatic Patients |
11:02 AM - 11:08 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 44.1 - Correlation Of Carotid Stump Pressure With Collateral Cerebral Circulation |
Web-Based Presentation | 44.2 - Does Endovascular Treatment Of Takayasu’s Disease Ever Work And When? |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Sunday
SESSION 45:
NEW DEVELOPMENTS IN CAS AND RELATED TECHNIQUES (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
11:09 AM - 11:14 AM | Why All The Landmark Trials Supporting CEA To Prevent Strokes From Carotid Stenosis Are Obsolete: When Is Carotid Intervention Indicated? |
11:15 AM - 11:20 AM | Debate 30: CEA Not CAS Is The Best Treatment For Most Patients With High-Grade Carotid Stenosis |
11:21 AM - 11:26 AM | Debate 30: CAS Not CEA Is The Best Treatment For Most Patients With High Grade Carotid Stenosis |
11:27 AM - 11:32 AM | Debate 30: Best Medical Treatment (BMRX) Should Be The Treatment Of Choice For Most Patients With Asymptomatic Carotid Stenosis: They Do Not Require Prophylactic CEA Or CAS |
11:33 AM - 11:38 AM | CAS vs. CEA: What Are The Relative Results For Symptomatic And Asymptomatic Patients From The SVS Registry? |
11:39 AM - 11:44 AM | Debate 31: No Patient Should Undergo CAS Without Embolic Brain Protection |
11:45 AM - 11:50 AM | Debate 31: Some Patients Should Undergo CAS Without Embolic Brain Protection |
11:51 AM - 11:56 AM | CAS Is The Treatment Of Choice For Post CEA Symptomatic Restenosis: When Is Observation And Medical Treatment Indicated? |
11:57 AM - 12:08 PM | Panel Discussion / Refreshments Available In 3rd Floor Foyer |
Moderator(s): TBD / TBD | |
12:09 PM - 12:14 PM | Current Status Of Gra- Scale Median (GSM) For Detecting Asymptomatic Carotid Plaques At Risk For Causing Stroke: Why Is There Controversy About The Value Of GSM In Assessing Plaque Vulnerability And Risk? |
12:15 PM - 12:20 PM | Is There A Role For CAS In The Presence Of A Carotid String Sign? |
12:21 PM - 12:26 PM | 10 Top Tips For CAS Without Complications |
12:27 PM - 12:32 PM | Subanalysis Of Flow Reversal System (FRS) For Embolic Protection: What Lessons Can Be Learned? |
12:33 PM - 12:38 PM | Comparison Of Filters And Flow Reversal For Brain Protection As Monitored By TCD And DWI MRI |
12:39 PM - 12:44 PM | Why Were The Results Of CREST And ICSS So Different: Therapeutic Implications |
12:45 PM - 12:50 PM | Analysis Of Filter Debris From CAS Procedures: Does It Correlate With Duplex GSM Findings And How Does It Help Choose The Best Means Of Embolic Protection? |
12:51 PM - 12:56 PM | Carotid Stent Fractures: Incidence And Implications |
12:57 PM - 1:02 PM | Open Surgical Technique Getting Exposure Of The ICA To The Base Of The Skull For Aneurysms, etc.: It's Better Than Dislocating The Jaw |
1:03 PM - 1:10 PM | Panel Discussion |
Web-Based Presentation | 45.1 - How Can The CREST And ICSS Results Be Reconciled? |
Web-Based Presentation | 45.2 - SVS CAS Registry Shows No Difference In Results Between Open And Closed Cell Stents |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Sunday
SESSION 46:
NEW CONCEPTS, ADVANCES, LATE BREAKING TRIALS AND DEVELOPMENTS (4-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
1:10 PM - 1:15 PM | Minimal Aortic Injury After Chest Trauma: Not All Patients Need Repair: A New Classification System |
1:15 PM - 1:19 PM | Current Thinking About The Biology Of AAAs: Is There Any Hope For Medical Treatment To Slow AAA Growth? |
Presenters(s):Matt M. Thompson, MD | |
1:20 PM - 1:24 PM | Leaving A Temporary Catheter In The AAA Sac After EVAR Permits Diagnosis And Treatment Of Type I And II Endoleaks |
1:25 PM - 1:29 PM | The Unballoon Aortic Dilating Device Improves Endograft Fixation Without Obstructing Flow Or Causing Graft Blow-Down |
1:30 PM - 1:34 PM | Preop Variables Predict Which Type II Endoleak Will Persist And Require Reintervention |
1:35 PM - 1:39 PM | Improved Techniques For Treating Acute SMA Occlusions In The Endovascular Era |
1:40 PM - 1:44 PM | A New Better Prosthetic Vascular Graft That Minimizes Suture Hole Bleeding |
1:45 PM - 1:49 PM | What Is The Role For Controlled Hypotension During TEVAR? |
1:50 PM - 1:54 PM | The Pin-Down Technique For Crossover Access Via An Aortobifemoral Graft With A Sharp Angle |
1:55 PM - 1:59 PM | Long-Term Results Of VAC On Vessel And Prosthesis For The Treatment Of Arterial Graft Infection |
2:00 PM - 2:06 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 46.1 - A New Simplified System For Measuring Internal Pressures Without A Hardwire Connection |
Web-Based Presentation | 46.2 - Improved Management Of Type II Endoleaks With Coil Embolization |
Web-Based Presentation | 46.3 - Vascular Injuries From Laparoscopic Procedures: Diagnosis And Treatment |
Web-Based Presentation | 46.4 - Advantages Of And Indications For Prasugrel Over Plavix For Platelet Inhibition: When Does It Matter? |
Web-Based Presentation | 46.5 - A New Simplified System To Evacuate Toxic Blood From Ischemic Limbs To Prevent Reperfusion Syndrome After Relief Of Severe Acute Limb Ischemia |
Web-Based Presentation | 46.6 - New Developments In Silver Acetate Impregnated Grafts For Use In Infected Fields |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Sunday
SESSION 47:
NEW CONCEPTS, RECENT ADVANCES AND DEVELOPMENTS (4-MINUTE TALKS)
xxxxxxxx
Moderators:TBD
|
|
x | |
2:07 PM - 2:11 PM | Tips And Tricks For Anterior Lumbar Spine Exposure |
2:12 PM - 2:16 PM | Advantages Of Stent-Grafts In TIPS Procedures |
2:17 PM - 2:21 PM | Comparison Of Brain Microemboli Resulting From CAS With Flow Reversal And CEA |
2:22 PM - 2:26 PM | New Biomarkers Of Activity Levels In Takayasu’s Arteritis: Can They Guide Treatment? |
2:27 PM - 2:31 PM | Percutaneous Device (ROX) To Create An Iliac AV Fistula To Improve Oxygenation For Patients With Hypoxic COPD: Status Of European And U.S. Trials |
2:32 PM - 2:36 PM | Infrainguinal Bypass Surgery For CLI Has Lower Mortality And Morbidity Than Amputation In Risk Matched Patients |
2:37 PM - 2:41 PM | Sideways Movement Of Endografts Is Predictive Of Adverse Events |
2:42 PM - 2:46 PM | In Lower Extremity Revascularization How Important Is Patency? |
2:47 PM - 2:51 PM | How To Predict Which Patients With A Small AAA Are Likely To Require Treatment |
2:52 PM - 2:56 PM | Promising Results Of A Spiral Flow Synthetic Vascular Graft: Theory And 2-Year Fem-Pop Results |
2:57 PM - 3:01 PM | Is EVAR The Treatment Of Choice For Aortoenteric Fistulas: Review Of World Experience |
3:02 PM - 3:06 PM | The Best Way To Treat Aortoiliac Occlusive Disease Is To Create A New Aortic Bifurcation With Covered Balloon Expandable Stent-Grafts |
3:07 PM - 3:11 PM | Role Of PET/CT With FDG Uptake To Assess The Importance Of The Dynamic Inflammatory Process In Arteriosclerosis And How It Can Be Modified By Statins |
3:12 PM - 3:19 PM | Panel Discussion |
3:19 PM - 3:30 PM | Raffle Prize Drawing For Fully Paid Clinician Attendees. You Must Be Present To Win. |
3:30 PM - 3:30 PM | Symposium Ends. Come Back Next Year – November 16-20, 2011. |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 47.1 - Is Arterial Compression Underestimated In TOS: Why And What Should Be Done About It? |
Web-Based Presentation | 47.2 - What Is The 30-Day, 1-Year And 5-Year Mortality For Open AAA Repair In A Northern European Population Based Study? Does Gender Matter? |
Web-Based Presentation | 47.3 - Anatomic Fixation Of Endografts At The Aortic Bifurcation Enables EVAR Treatment Of Difficult Necks With Good Long-Term Results Without Migration |
Web-Based Presentation | 47.4 - Predictors Of Cardiac Morbidity And Mortality During EVAR |
Web-Based Presentation | 47.5 - Endovascular Techniques To Improve Results With Open Repair For Ruptured AAAs |
END OF SESSION 47 |